Atlas FDA

SAPIEN 3 TRANSCATHETER HEART VALVE AND ACCESSORIES

FDA premarket approval P140031/S194 · decided 2025-10-10

Approval details

PMA number
P140031
Supplement
S194
Supplement type
Normal 180 Day Track No User Fee
Supplement reason
Postapproval Study Protocol
Trade name
SAPIEN 3 TRANSCATHETER HEART VALVE AND ACCESSORIES
Generic name
Aortic valve, prosthesis, percutaneously delivered
Applicant
Edwards Lifesciences, LLC
Date received
2025-09-12
Decision date
2025-10-10
Days to decision
28 days
Decision code
APPR
Product code
NPT
Advisory committee
Cardiovascular
Expedited review
No
Location
Irvine, CA
Statement
Approval of the revised protocol for the "Continued Follow-up of 'EARLY TAVR' Premarket Cohort" postapproval study ordered under P140031/S182.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
Respiration Rate algorithm (K251326)Edwards Lifesciences, LLC2026-06-11
HemoSphere Nano Monitor (HSNANO1) (K253186)Edwards Lifesciences, LLC2026-02-24
Edwards MC3 Tricuspid annuloplasty ring (4900) (K251982)Edwards Lifesciences, LLC2025-09-23
Carpentier-Edwards Physio Annuloplasty Ring (4450) (K251688)Edwards Lifesciences, LLC2025-09-17
Hypertension Prediction Index (HePI) Algorithm (K242518)Edwards Lifesciences, LLC2025-05-15
FloTrac sensors; FloTrac Jr sensors; Acumen IQ sensors; VolumeView sensors (K242909)Edwards Lifesciences, LLC2025-03-21
Fogarty Thru-Lumen Embolectomy Catheter (K240078)Edwards Lifesciences, LLC2024-08-28
Acumen Assisted Fluid Management (AFM) Software Feature (K233984)Edwards Lifesciences, LLC2024-08-02